Physician

Anthony J Ricketti, M.D.

According to 2025 Medicare claims, Anthony Ricketti, M.D. (NPI: 1285680850) practices allergy/immunology in the Trenton-Princeton, NJ market, with the plurality of this provider's patient population coming from Mercer, NJ. This provider's primary affiliated billing organization is MERCER ALLERGY & PULMONARY ASSOCIATES, LLC (NPI: 1073936399; TIN: 464242605) and primary practice location at 08619-3830.

Ricketti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 344 traditional Medicare patients, billed 4,625 HCPCS/CPT codes, and received $110,803 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,638 prescription claims across 529 beneficiaries totaling $3,899,544 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 331 claims. Open Payments data shows 180 records totaling $48,935. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $247,288 to $110,803. In contrast, Part D prescription costs have moved sharply higher in recent years, from $1,099,689 to $3,899,544. For DME billing, this smaller-volume category moved from a higher plateau to a lower plateau, from $34,372 to $11,582.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	576	10,523	$247,288
2016	514	6,627	$168,564
2017	408	6,096	$144,362
2018	396	5,262	$139,328
2019	329	4,726	$114,334
2020	291	3,331	$82,916
2021	343	5,088	$127,982
2022	343	4,396	$105,666
2023	335	5,487	$118,786
2024	344	4,625	$110,803

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	423	3,047	$1,099,689
2016	396	2,578	$974,287
2017	458	3,343	$1,195,313
2018	455	3,318	$1,293,869
2019	459	3,429	$1,662,140
2020	468	3,489	$1,902,096
2021	487	3,431	$2,220,758
2022	502	3,552	$2,576,107
2023	513	3,650	$2,986,895
2024	529	3,638	$3,899,544

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	96	648	$48,123
2016	102	731	$46,751
2017	73	642	$42,273
2018	103	631	$44,846
2019	46	459	$30,186
2020	65	563	$41,576
2021	51	535	$34,727
2022	48	517	$23,785
2023	14	443	$18,981
2024	22	331	$13,767

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	239	456	$99
94727	Test to determine lung volumes using gas dilution or washout	114	124	$37
94375	Test to measure rate of airflow	114	124	$33
94060	Test to measure expiratory airflow and volume changes before and after medication administration	127	152	$32
94200	Test to measure largest amount of air breathed in an out	114	124	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	46	1,380	$604,760
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	496	21,390	$443,259
Dupixent Syringe	Dupilumab	92	2,576	$340,146
Nucala	Mepolizumab	48	1,344	$172,672
Xolair	Omalizumab	44	1,232	$172,201

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	11	86	$5,890
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	35	$2,101
E1392	Portable oxygen concentrator, rental	Y	N/R	59	$2,091
J7605	Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms	N	N/R	25	$1,531
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	11	58	$1,346

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	180	$48,935	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anthony J. Ricketti, M.D.?

Tedicare shows public-source Medicare data for Anthony J. Ricketti, M.D. (NPI 1285680850), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anthony J. Ricketti, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anthony J. Ricketti, M.D.?

Anthony J. Ricketti, M.D. is linked to MERCER ALLERGY & PULMONARY ASSOCIATES, LLC (billing NPI 1073936399) in the available physician profile data.

Does Anthony J. Ricketti, M.D. have Open Payments data?

Anthony J. Ricketti, M.D. has 180 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.